This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eisai R&D Management Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kenzo Arai: Innovator in Antibody-Drug Conjugates
Introduction
Kenzo Arai is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates. His innovative work has the potential to enhance therapeutic options in cancer treatment.
Latest Patents
Kenzo Arai holds a patent for "Herboxidiene Antibody-Drug Conjugates and Methods of Use." This patent represents a significant advancement in targeted cancer therapies, showcasing his expertise in combining antibodies with drug delivery systems.
Career Highlights
Arai is currently associated with Eisai R&D Management Co., Ltd., where he continues to push the boundaries of medical research and innovation. His work has been instrumental in developing new therapeutic strategies that aim to improve patient outcomes.
Collaborations
Kenzo Arai has collaborated with talented professionals such as Nathan Fishkin and Thiwanka Samarakoon. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Kenzo Arai's contributions to the field of biotechnology, particularly through his patent on antibody-drug conjugates, highlight his role as an innovator. His work at Eisai R&D Management Co., Ltd. continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile